Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-264241
Filing Date
2023-10-26
Accepted
2023-10-26 18:57:55
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 57764
2 GRAPHIC g541146g04y55.jpg GRAPHIC 2678
3 GRAPHIC g541146g15z70.jpg GRAPHIC 3042
4 GRAPHIC g541146g54i65.jpg GRAPHIC 2680
  Complete submission text file 0001193125-23-264241.txt   70854
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)